ArticlePloS one2025

Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis.

Hiam Chemaitelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.